Mirae Asset Global Investments Co., Ltd. Sangamo Therapeutics, Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

$54.3 Billion
Q1 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 493,431 shares of SGMO stock, worth $222,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares

493,431

Holding current value

$222,043

% of portfolio

0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$0.42 - $1.38 $207,241 - $680,934	493,431 New	493,431 $330,000
Q3 2023 Oct 26, 2023	BUY	$0.58 - $1.47 $36,229 - $91,823	62,465 Added 10.18%	676,189 $405,000
Q2 2023 Aug 10, 2023	BUY	$1.11 - $1.74 $98,172 - $153,892	88,444 Added 16.84%	613,724 $797,000
Q1 2023 May 04, 2023	BUY	$1.66 - $3.67 $46,436 - $102,664	27,974 Added 5.63%	525,280 $924,000
Q4 2022 Feb 09, 2023	SELL	$2.77 - $5.07 $383,611 - $702,134	-138,488 Reduced 21.78%	497,306 $1.56 Million

Q3 2022 Nov 10, 2022	BUY	$4.27 - $6.39 $350,426 - $524,408	82,067 Added 14.82%	635,794 $3.12 Million
Q2 2022 Jul 26, 2022	BUY	$3.28 - $6.21 $555,415 - $1.05 Million	169,334 Added 44.05%	553,727 $2.29 Million
Q1 2022 May 10, 2022	SELL	$5.23 - $7.82 $370,723 - $554,312	-70,884 Reduced 15.57%	384,393 $2.23 Million
Q4 2021 Feb 08, 2022	BUY	$7.29 - $10.97 $696,916 - $1.05 Million	95,599 Added 26.58%	455,277 $3.42 Million
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $509,749 - $679,477	56,576 Added 18.67%	359,678 $3.24 Million
Q2 2021 Aug 11, 2021	BUY	$10.17 - $12.64 $407,817 - $506,864	40,100 Added 15.25%	303,102 $3.63 Million
Q1 2021 May 13, 2021	BUY	$10.88 - $17.05 $1.3 Million - $2.03 Million	119,168 Added 82.85%	263,002 $3.3 Million
Q4 2020 Feb 10, 2021	BUY	$9.23 - $18.18 $305,688 - $602,103	33,119 Added 29.91%	143,834 $2.24 Million
Q3 2020 Nov 12, 2020	BUY	$9.38 - $12.48 $335,306 - $446,122	35,747 Added 47.68%	110,715 $1.05 Million
Q2 2020 Aug 11, 2020	BUY	$6.21 - $11.83 $167,061 - $318,250	26,902 Added 55.97%	74,968 $672,000
Q1 2020 May 12, 2020	BUY	$5.05 - $8.85 $26,547 - $46,524	5,257 Added 12.28%	48,066 $306,000
Q4 2019 Feb 12, 2020	BUY	$8.03 - $11.7 $82,805 - $120,650	10,312 Added 31.73%	42,809 $358,000
Q3 2019 Nov 12, 2019	BUY	$9.05 - $12.22 $294,097 - $397,113	32,497 New	32,497 $294,000

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $70.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Sangamo Therapeutics, Inc Transaction History